II. Definitions
III. Types: Hyperacute Graft Rejection
- Onset within hours to days of Transplantation
- Caused by pre-existing host Antibody (inadequately cross-matched graft)
- ABO Incompatibility (Blood Transfusion Reaction)
- HLA incompatibility
- Mechanism
- Antibodies bind graft endothelium, activating complement
- Endothelial inflammation and ultimately graft thrombosis results
IV. Types: Acute Graft Rejection
- Onset within days to weeks of Transplantation (<100 days after transplant)
- Mechanism
- CD8+ T Cell activation and graft destruction
- Monocyte activation (by T Cells) results in delayed type Hypersensitivity
- B-Cell Antibody production against graft vessel wall Antigens
- Findings
- Gastrointestinal symptoms
- Nausea and Vomiting
- Diarrhea
- Jaundice (with Total Bilirubin increase)
- Maculopapular rash
- Lesions may involve palms and soles
- Pain and Pruritus
- May appear similar to Stevens Johnson Syndrome
- May progress to Erythroderma or Bullous Disease
- Gastrointestinal symptoms
V. Types: Chronic Graft Rejection
- Onset within months to years of Transplantation (>100 days after transplant)
- Mechanism
- Immune response with graft chronic inflammation
- Results in vessel intimal thickening and gradual vessel narrowing (Arteriosclerosis) to Occlusion
- Findings: Chronic Autoimmune Effects
- Sclerosis
- Sicca syndrome and Conjunctivitis
- Lichenoid skin lesions
- Esophageal Webs and strictures
- Mucositis and mucous membrane ulcerations
- Bronchiolitis Obliterans (Shortness of Breath, cough, Wheezing)
VI. References
- Claudius, Ruttan and DeFabio in Swadron (2022) EM:Rap 22(11): 13